DekaBank Deutsche Girozentrale Purchases 2,256 Shares of Waters Co. (NYSE:WAT)

DekaBank Deutsche Girozentrale raised its position in Waters Co. (NYSE:WAT) by 4.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,073 shares of the medical instruments supplier’s stock after buying an additional 2,256 shares during the quarter. DekaBank Deutsche Girozentrale owned about 0.07% of Waters worth $10,747,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. MERIAN GLOBAL INVESTORS UK Ltd bought a new stake in shares of Waters during the 1st quarter valued at $70,947,000. FMR LLC raised its stake in shares of Waters by 88.8% during the 1st quarter. FMR LLC now owns 382,877 shares of the medical instruments supplier’s stock valued at $96,374,000 after purchasing an additional 180,046 shares during the period. AJO LP raised its stake in shares of Waters by 188.7% during the 1st quarter. AJO LP now owns 186,568 shares of the medical instruments supplier’s stock valued at $46,961,000 after purchasing an additional 121,953 shares during the period. First Trust Advisors LP raised its stake in shares of Waters by 1,148.3% during the 2nd quarter. First Trust Advisors LP now owns 86,505 shares of the medical instruments supplier’s stock valued at $18,619,000 after purchasing an additional 79,575 shares during the period. Finally, Northern Trust Corp raised its stake in shares of Waters by 5.9% during the 1st quarter. Northern Trust Corp now owns 991,892 shares of the medical instruments supplier’s stock valued at $249,670,000 after purchasing an additional 54,938 shares during the period. Hedge funds and other institutional investors own 96.08% of the company’s stock.

Several research firms recently commented on WAT. Wolfe Research began coverage on Waters in a research report on Thursday, May 30th. They set an “underperform” rating for the company. Bank of America cut Waters from a “neutral” rating to an “underperform” rating in a research report on Tuesday, July 16th. UBS Group reduced their target price on Waters from $248.00 to $230.00 and set a “neutral” rating for the company in a research report on Wednesday, April 24th. Barclays reduced their target price on Waters from $218.00 to $210.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 24th. Finally, ValuEngine cut Waters from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Five analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $210.54.

WAT stock traded up $3.28 during trading on Friday, hitting $205.54. 651,300 shares of the company traded hands, compared to its average volume of 573,576. The firm has a market capitalization of $13.35 billion, a PE ratio of 24.79, a P/E/G ratio of 2.24 and a beta of 1.07. Waters Co. has a 1 year low of $167.93 and a 1 year high of $255.21. The company has a 50-day moving average of $214.23 and a 200-day moving average of $223.97. The company has a debt-to-equity ratio of 2.00, a quick ratio of 2.07 and a current ratio of 2.65.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share for the quarter, beating the consensus estimate of $2.11 by $0.03. The company had revenue of $599.20 million during the quarter, compared to analysts’ expectations of $601.46 million. Waters had a return on equity of 50.64% and a net margin of 24.09%. Waters’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.95 EPS. Sell-side analysts expect that Waters Co. will post 9.01 EPS for the current year.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: What Factors Can Affect Return on Equity?

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.